Medicare Enrolled
Dr. Dilsher Dhoot, M.D.
Retina Specialist (Ophthalmology) Physician · Santa Barbara, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Dhoot from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Dhoot?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Dhoot
Dr. Dilsher Dhoot is a retina specialist physician in Santa Barbara, CA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Dhoot performed 42,593 Medicare services across 6,851 unique beneficiaries.
Between the years covered by Open Payments, Dr. Dhoot received a total of $1,784,776 from 40 pharmaceutical and/or device companies across 1649 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in retina specialist (ophthalmology) physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Dhoot is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 8% volume in CA
$1,784,776 industry payments
Medicare Practice Summary
Medicare Utilization ↗42,593
Medicare services
Top 8% in CA for retina specialist (ophthalmology) physician
6,851
Unique beneficiaries
$126
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~2,366 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Eye injection (Vabysmo/faricimab) An injection of faricimab-svoa, a medication administered in 0.1 mg doses. |
21,780 | $29 | $70 |
| Aflibercept eye injection (Eylea) | 3,542 | $687 | $1,250 |
| Ranibizumab-eqrn injection, 0.1 mg An injection of the biosimilar medication ranibizumab-eqrn (Cimerli) in a 0.1 mg dose. |
3,125 | $219 | $718 |
| Retinal imaging (OCT scan) This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye. |
3,059 | $34 | $125 |
| Eye injection for retinal disease A procedure involving the administration of medication directly into the eye. |
2,704 | $109 | $977 |
| Retinal photography (fundus photo) This procedure involves taking photographs of the retina, the light-sensitive tissue at the back of the eye. It is used to document the condition of the eye's interior structures. |
1,702 | $29 | $95 |
| Eye exam, established patient, focused A limited examination of the visual system for an existing patient. The provider focuses on a specific eye-related concern or symptom. |
1,688 | $75 | $125 |
| Comprehensive eye exam, established patient A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider. |
1,609 | $94 | $175 |
| Pegcetacoplan intravitreal injection, 1 mg An injection of pegcetacoplan administered into the vitreous humor of the eye. The dose specified is 1 milligram. |
1,050 | $120 | $440 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
381 | $1,458 | $3,782 |
| Extended exam of back of eye with optic nerve drawing A detailed examination of the posterior section of the eye, including the optic nerve, with documentation through drawing. |
352 | $12 | $200 |
| Injection, ranibizumab, 0.1 mg | 269 | $181 | $500 |
| Dexamethasone intravitreal implant injection An injection of a dexamethasone implant placed inside the eye. This procedure delivers medication directly into the vitreous cavity of the eye. |
224 | $159 | $500 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
205 | $130 | $220 |
| Retinal angiography with dye injection This procedure uses a special camera to examine the blood vessels in the retina after a dye has been injected into the body. |
197 | $119 | $175 |
| Comprehensive eye exam, new patient A comprehensive examination of the visual system performed for a new patient. |
191 | $119 | $204 |
| Fluorescein angiography of the eye An imaging test of the front part of the eye using a special camera after a dye is injected to visualize blood flow. |
115 | $126 | $200 |
| Ultrasound of eye tissue and structures A diagnostic imaging test that uses sound waves to create pictures of the eye's internal tissues and structures. |
98 | $40 | $225 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
72 | $73 | $150 |
| Compounded drug, not otherwise classified A medication prepared specifically for an individual patient by a pharmacist or physician, tailored to meet unique needs that cannot be fulfilled by commercially available products. |
60 | $73 | $100 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
58 | $86 | $170 |
| Retinal laser treatment for leaking blood vessels This procedure uses a laser to seal leaking blood vessels in the retina. It is performed to prevent vision loss caused by fluid leakage from damaged retinal vessels. |
40 | $270 | $1,600 |
| Retinal photocoagulation to prevent detachment This procedure uses laser light to create small burns on the retina. It is performed to help prevent the retina from detaching from the back of the eye. |
22 | $197 | $1,600 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
20 | $20 | $40 |
| Extended eye exam with retinal drawing A detailed examination of the back of the eye that includes creating a drawing of the retina. |
18 | $20 | $200 |
| Retinal detachment repair with fluid drainage A surgical procedure to reattach a detached retina by draining excess fluid from the space between the lens and the retina. |
12 | $963 | $4,555 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$1,784,776
Total received (2018-2024)
Avg $254,968/year across 7 years
Top 1% in CA for retina specialist (ophthalmology) physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
40
Companies
1,649
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,582,513 (88.7%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$190,062 (10.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,947 (0.7%)
Financial / Ownership
Ownership or investment interests, royalties, and licensing fees
$255 (0.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$387,860
2023
$477,265
2022
$229,271
2021
$173,500
2020
$64,637
2019
$300,383
2018
$151,861
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Regeneron Healthcare Solutions, Inc.
$118,423
Ocular Therapeutix, Inc.
$98,274
Apellis Pharmaceuticals, Inc.
$97,282
Genentech USA, Inc.
$30,205
Alimera Sciences, Inc.
$19,045
Regeneron Pharmaceuticals, Inc.
$5,790
EyePoint Pharmaceuticals US, Inc.
$4,833
Bausch & Lomb Americas Inc.
$4,284
BioCryst Pharmaceuticals, Inc.
$2,724
Roche Products Limited
$2,520
ABBVIE INC.
$1,221
Beaver-Visitec International, Inc.
$1,200
NEW WORLD MEDICAL,INC.
$535
Genentech, Inc.
$461
Astellas Pharma US Inc
$344
Harrow Eye, LLC
$301
Topcon Healthcare, Inc.
$146
Janssen Pharmaceuticals, Inc
$85
Sandoz Inc.
$73
Coherus Biosciences Inc.
$68
Biogen, Inc.
$46
Top 3 companies account for 81.0% of 2024 payments
All-time payments by company (2018-2024) ›
Regeneron Healthcare Solutions, Inc.
$708,899
Apellis Pharmaceuticals, Inc.
$255,170
Genentech USA, Inc.
$222,985
Alimera Sciences, Inc.
$114,921
Coherus Biosciences Inc.
$107,031
Ocular Therapeutix, Inc.
$106,829
Novartis Pharmaceuticals Corporation
$102,379
EyePoint Pharmaceuticals US, Inc.
$67,803
Roche Products Limited
$23,267
F. Hoffmann-La Roche AG
$15,240
Regeneron Pharmaceuticals, Inc.
$14,194
NOVARTIS PHARMACEUTICALS CORPORATION
$8,650
Bausch & Lomb Americas Inc.
$6,846
Genentech, Inc.
$4,876
Alcon Vision LLC
$4,695
Carl Zeiss Meditec, Inc.
$4,259
Allergan, Inc.
$4,253
BioCryst Pharmaceuticals, Inc.
$2,724
Optos, Inc.
$2,000
Allergan Inc.
$1,664
ABBVIE INC.
$1,297
Beaver-Visitec International, Inc.
$1,200
Astellas Pharma US Inc
$636
NotalVision
$600
NEW WORLD MEDICAL,INC.
$535
Harrow Eye, LLC
$301
Biogen, Inc.
$297
Alcon Laboratories Inc
$291
US Retina LLC
$255
Topcon Healthcare, Inc.
$146
AbbVie Inc.
$127
Janssen Pharmaceuticals, Inc
$85
Sandoz Inc.
$73
Hoffmann-La Roche Limited
$70
Mallinckrodt LLC
$59
Ortho Dermatologics, a division of Bausch Health US, LLC
$33
Mallinckrodt Hospital Products Inc.
$28
ThromboGenics, Inc.
$23
Carl Zeiss Meditec AG
$19
Bausch & Lomb, a division of Bausch Health US, LLC
$15
Top 3 companies account for 66.5% of all-time payments
Associated products mentioned in payments ›
ACTHAR · BEOVU · BROLUCIZUMAB · BYOOVIZ · Cimerli · Constellation · DEXTENZA · DEXYCU · EYLEA · EYLEA AFLIBERCEPT INJECTION · EYLEA HD · EYP-1901 · FLAREX · ForeseeHome · IHEEZO · ILUVIEN · Iluvien · Izervay · Jetrea · Kahook Dual Blade · LUMIGAN · Lucentis · Luxor · MIEBO · Non-Covered Product · None Specified · OZURDEX · PANORAMIC OPHTHALMOSCOPE · PROLENSA · SUSVIMO · Susvimo · Syfovre · VABYSMO · VISUDYNE · VISULAS 532s · VYZULTA · Vabysmo · XERESE · XIPERE · YUTIQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (89%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in retina specialist (ophthalmology) physician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for retina specialist (ophthalmology) physician in CA.
Geographic Context
Retina specialist physicians within 10 mi
3
Per 100K population
0.7
County median income
$95,977
Nearest hospital
SANTA BARBARA COUNTY PSYCHIATRIC HEALTH FACILITY
5.0 mi
5.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Dhoot is a mixed practice specialist, with above-average Medicare volume (top 8% in CA), with speaking/promotional industry engagement in the top 1% of CA peers, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Dhoot experienced with eye injection (vabysmo/faricimab)?
Based on Medicare claims data, Dr. Dhoot performed 21,780 eye injection (vabysmo/faricimab) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Dhoot receive payments from pharmaceutical companies?
Yes. Dr. Dhoot received a total of $1,784,776 from 40 companies across 1,649 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Dhoot's costs compare to other retina specialist physicians in Santa Barbara?
Dr. Dhoot's average Medicare payment per service is $126. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Dhoot) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Retina Specialist Physicians in Santa Barbara
Browse retina specialist physicians in Santa Barbara ranked by procedure volume and transparency data.
Highest volume
Top Retina Specialist Physicians in CA
Retina specialist physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Retina Specialist Physicians in CA
Which CA retina specialist physicians receive the most from drug and device companies.
By company
Regeneron Healthcare Solutions, Inc. Payments to Doctors
See all physicians who received payments from Regeneron Healthcare Solutions, Inc.
By company
Apellis Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Apellis Pharmaceuticals, Inc.
By company
Genentech USA, Inc. Payments to Doctors
See all physicians who received payments from Genentech USA, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology